Telemedicine Nurse-Led Intervention for Rural Cancer Survivors
Launched by UNIVERSITY OF VIRGINIA · Feb 10, 2020
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new support program called CARING, which is designed to help people who have recently finished treatment for head and neck cancer, especially those living in rural areas. The program is led by nurses and uses telemedicine, meaning patients can meet with their healthcare providers through video calls from the comfort of their homes. The trial aims to see how effective this program is compared to regular care, how much it costs, and what patients think about using telemedicine for their follow-up care.
To participate in the trial, individuals must be at least 18 years old, have a diagnosis of head and neck cancer, and be within three months of completing their treatment. If eligible, participants will be randomly assigned to one of three groups: receiving the CARING program in person, through telemedicine, or getting standard care. Throughout the study, participants will answer questions about their needs and quality of life, and their healthcare costs will also be tracked. This research aims to improve support for cancer survivors and make sure their needs are met, especially for those in rural communities.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Diagnosis of Head and Neck Cancer
- • Anticipated to be within 3 months of end of treatment
- • At least 18 years old
- Exclusion Criteria:
- • -
About University Of Virginia
The University of Virginia (UVA) is a prestigious academic institution renowned for its commitment to advancing medical research and improving patient care through innovative clinical trials. With a focus on interdisciplinary collaboration, UVA leverages its extensive resources and expertise in various fields, including medicine, engineering, and public health, to drive cutting-edge studies that address pressing health challenges. The university's clinical trial programs aim to translate scientific discoveries into effective treatments, ensuring the highest standards of ethical practice and participant safety. Through its strong emphasis on community engagement and education, UVA fosters a culture of research that not only contributes to the scientific community but also enhances the well-being of the populations it serves.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Pamela B DeGuzman, PhD
Principal Investigator
University of Virginia
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials